Literature DB >> 24760495

Transcatheter aortic valve replacement program development: recommendations for best practice.

Marian C Hawkey1, Sandra B Lauck, Elizabeth M Perpetua, Jill Fowler, Susan Schnell, Martina Speight, Karen Holst Lisby, John G Webb, Martin B Leon.   

Abstract

BACKGROUND: Transcatheter aortic valve replacement (TAVR) is an increasingly available therapy for the management of aortic stenosis in higher risk populations. Beyond addressing the procedural challenges, centers must attend to the unique requirements of developing TAVR programs from referral to follow-up. AIM: The aim of this article is to outline the recommendations for best practice for program development from centers with early and extensive experience. RECOMMENDATIONS: The guideline-recommended Heart Team approach requires interdisciplinary agreements, delineation of roles and responsibilities, and the development of the role of the TAVR Coordinator. To support appropriate case selection, the screening and evaluation must be organized in a comprehensive clinic visit. In addition to the multimodality imaging tests, the assessment of functional status and frailty is pivotal to the eligibility decision. Throughout the TAVR trajectory, careful attention must be afforded to the integration of geriatric best practices. Pre-procedure care requires patient and family education to manage expectations and facilitate early discharge planning. Peri-procedural care planning, including equipment requirements, monitoring protocols, and emergency intervention agreements, contributes to procedural success. The aims of post-procedure care are to monitor the recovery, facilitate the rapid return to baseline status, and optimize length of stay. TAVR programs require data management strategies to facilitate and monitor program growth, support program evaluation, and meet the requirements for submission to national registries.
CONCLUSION: TAVR represents a paradigm shift in the management of structural heart disease. Programmatic success and patient outcomes depend on the development of a comprehensive and collaborative program tailored to TAVR.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  aortic valve disease; percutaneous intervention; program development; transcatheter valve replacement

Mesh:

Year:  2014        PMID: 24760495     DOI: 10.1002/ccd.25529

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Improved outcomes following implementation of an acute gastrointestinal bleeding multidisciplinary protocol.

Authors:  Tyler J Loftus; Kristina L Go; Steven J Hughes; Chasen A Croft; Robert Stephen Smith; Philip A Efron; Frederick A Moore; Scott C Brakenridge; Alicia M Mohr; Janeen R Jordan
Journal:  J Trauma Acute Care Surg       Date:  2017-07       Impact factor: 3.313

2.  In vitro study of coronary flow occlusion in transcatheter aortic valve implantation.

Authors:  Zheng-Fu He; Wei-Ming Zhang; George Lutter; Rene Quaden; Jochen Cremer; Xiu-Jun Cai
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

Review 3.  Palliative care in end-stage valvular heart disease.

Authors:  Jill M Steiner; Stephanie Cooper; James N Kirkpatrick
Journal:  Heart       Date:  2017-08       Impact factor: 5.994

Review 4.  Transition to palliative care when transcatheter aortic valve implantation is not an option: opportunities and recommendations.

Authors:  Sandra B Lauck; Jennifer A Gibson; Jennifer Baumbusch; Sandra L Carroll; Leslie Achtem; Gil Kimel; Cindy Nordquist; Anson Cheung; Robert H Boone; Jian Ye; David A Wood; John G Webb
Journal:  Curr Opin Support Palliat Care       Date:  2016-03       Impact factor: 2.302

5.  Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes.

Authors:  Sandra Lauck; Jacqueline Forman; Britt Borregaard; Janarthanan Sathananthan; Leslie Achtem; Gemma McCalmont; Douglas Muir; Marian C Hawkey; Amanda Smith; Bettina Højberg Kirk; David A Wood; John G Webb
Journal:  Eur J Cardiovasc Nurs       Date:  2020-06-04       Impact factor: 3.908

6.  The COORDINATE Pilot Study: Impact of a Transcatheter Aortic Valve Coordinator Program on Hospital and Patient Outcomes.

Authors:  Katja Bohmann; Christof Burgdorf; Tobias Zeus; Michael Joner; Héctor Alvarez; Kira Lisanne Berning; Maren Schikowski; Albert Markus Kasel; Gesine van Mark; Cornelia Deutsch; Jana Kurucova; Martin Thoenes; Derk Frank; Steffen Wundram; Peter Bramlage; Barbara Miller; Verena Veulemans
Journal:  J Clin Med       Date:  2022-02-23       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.